CAMILLO GUALTIERI: Open Payments
NPI 1083684732 · CHAPEL HILL, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$835 in 45 payments from 18 companies in 2025. Trend: 2023 $821 · 2024 $1,289 · 2025 $835
Food & beverage: $835
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $189 |
| Otsuka America Pharmaceutical, Inc. | 7 | $149 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $92 |
| E.R. Squibb & Sons, L.L.C. | 3 | $53 |
| Corium, LLC | 2 | $46 |
| Vanda Pharmaceuticals Inc. | 2 | $40 |
| Lilly USA, LLC | 2 | $31 |
| Alkermes, Inc. | 1 | $30 |
| ACADIA Pharmaceuticals Inc | 2 | $28 |
| Collegium Pharmaceutical, Inc. | 1 | $24 |
Products named: VRAYLAR, REXULTI, CAPLYTA, COBENFY, Azstarys, HETLIOZ, AMYVID, ARISTADA.
Industry payments across NC — which companies pay providers there.
